MedTrace Logo

The Efficacy of Three Months-prednisolone Therapy for Chronic Eosinophilic Pneumonia

NCT00632554 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2014-09-19

No results posted yet for this study

Summary

A comparison of 3 months-prednisolone administration with 6 months-prednisolone therapy in the treatment of chronic eosinophilic pneumonia. Three months-prednisolone administration may be as effective as 6 months-therapy.

Conditions

Interventions

DRUG

prednisolone 0.5 mg/kg/day for three months

period of treatment

DRUG

prednisolone 0.5 mg/kg/day for six months

period of therapy

Sponsors & Collaborators

  • Hamamatsu University

    lead OTHER

Principal Investigators

  • Kingo Chida, MD, PhD · Hamamatsu University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00632554 on ClinicalTrials.gov